- €158.23m
- €259.23m
- €1.15bn
- 41
- 91
- 56
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.42 | ||
| Price to Tang. Book | 1.15 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.14 | ||
| EV to EBITDA | 6.65 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.39% | ||
| Return on Equity | -7.89% | ||
| Operating Margin | 0.35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1,975 | 1,709 | 1,760 | 1,145 | 1,150 | 1,155.15 | 1,196.1 | -12.1% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +14.07 | -97.47 | +949.4 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Agfa Gevaert NV is a Belgium-based company that develops, produces and distributes analog and digital imaging systems and information technology (IT) solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications. The Company’s activities are divided into three independent business groups: Agfa Graphics, its dominant segment, which offers integrated pre-press solutions to the printing industry; Agfa HealthCare, which supplies hospitals and other healthcare centers with systems for capturing, processing and managing diagnostic images; and Agfa Specialty Products, which supplies a film-based products and high-tech solutions to business-to-business customers outside the graphic and healthcare markets. The Company is active worldwide through more than 40 wholly-owned sales organizations and runs manufacturing sites in Argentina, Brazil, China, France, Germany, Italy, Japan, South Korea, Taiwan the United Kingdom and the United States.
Directors
- Frank Aranzana CHM (63)
- Pascal Juery CEO (57)
- Dirk De Man CFO (55)
- Gunther Koch CHO
- Christian Reinaudo EDR (66)
- Luc Delagaye EXB (61)
- Luc Thijs EXB (56)
- Wilfried Van Lishout SEC (56)
- Helen Routh IND (58)
- Hilde Laga NID (65)
- Mark Pensaert NID (56)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- June 10th, 1964
- Public Since
- May 31st, 1999
- No. of Employees
- 5,026
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Euronext - Brussels- Shares in Issue
- 154,820,528
- Address
- Septestraat 27, MORTSEL, 2640
- Web
- https://www.agfa.com/corporate/
- Phone
- +32 34442111
- Contact
- Viviane Dictus
- Auditors
- KPMG Bedrijfsrevisoren
Latest News for AGFB
Upcoming Events for AGFB
Q3 2024 AGFA Gevaert NV Earnings Release
Q4 2024 AGFA Gevaert NV Earnings Release
Similar to AGFB
Biocartis NV
Euronext - Brussels
Ion Beam Applications SA
Euronext - Brussels
Nyxoah SA
Euronext - Brussels
Onward Medical NV
Euronext - Brussels
FAQ
As of Today at 19:08 UTC, shares in Agfa Gevaert NV are trading at €1.02. This share price information is delayed by 15 minutes.
Shares in Agfa Gevaert NV last closed at €1.02 and the price had moved by -37.53% over the past 365 days. In terms of relative price strength the Agfa Gevaert NV share price has underperformed the FTSE Global All Cap Index by -46.08% over the past year.
The overall consensus recommendation for Agfa Gevaert NV is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAgfa Gevaert NV does not currently pay a dividend.
Agfa Gevaert NV does not currently pay a dividend.
Agfa Gevaert NV does not currently pay a dividend.
To buy shares in Agfa Gevaert NV you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.02, shares in Agfa Gevaert NV had a market capitalisation of €158.23m.
Here are the trading details for Agfa Gevaert NV:
- Country of listing: Belgium
- Exchange: BRU
- Ticker Symbol: AGFB
Based on an overall assessment of its quality, value and momentum Agfa Gevaert NV is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Agfa Gevaert NV is €1.40. That is 36.99% above the last closing price of €1.02.
Analysts covering Agfa Gevaert NV currently have a consensus Earnings Per Share (EPS) forecast of -€0.08 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Agfa Gevaert NV. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -18.67%.
As of the last closing price of €1.02, shares in Agfa Gevaert NV were trading -11.95% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Agfa Gevaert NV PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Agfa Gevaert NV's management team is headed by:
- Frank Aranzana - CHM
- Pascal Juery - CEO
- Dirk De Man - CFO
- Gunther Koch - CHO
- Christian Reinaudo - EDR
- Luc Delagaye - EXB
- Luc Thijs - EXB
- Wilfried Van Lishout - SEC
- Helen Routh - IND
- Hilde Laga - NID
- Mark Pensaert - NID